| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
9,641 |
9,171 |
$626K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
7,895 |
7,654 |
$542K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
5,507 |
5,322 |
$320K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
762 |
747 |
$60K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
3,714 |
3,589 |
$23K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
3,131 |
1,867 |
$11K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
171 |
159 |
$10K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
3,144 |
3,031 |
$5K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
120 |
120 |
$3K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
14 |
14 |
$1K |
| 90674 |
|
117 |
115 |
$505.96 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
93 |
82 |
$14.30 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
37 |
30 |
$0.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
16 |
13 |
$0.00 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
14 |
14 |
$0.00 |
| 71046 |
Radiologic examination, chest; 2 views |
26 |
26 |
$0.00 |
| 81025 |
|
42 |
42 |
$0.00 |